What is the ticker symbol for Allakos?

Allakos trades under the ticker ALLK on NASDAQ.

What sector does Allakos operate in?

Allakos is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ALLK in a portfolio?

PortView shows ALLK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Allakos (ALLK) Stock Analysis

NASDAQHealthcareBiotechnology

$0.33+0.22%

1-year price historyRange $0.22 – $1.50

52-week range$0.33

$0.22$1.56

What Allakos does

Allakos Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing therapeutic agents. These treatments are designed to target specific immunomodulatory receptors on immune effector cells, addressing a spectrum of allergic, inflammatory, and proliferative conditions. The company's flagship investigational product is lirentelimab (AK002), a monoclonal antibody. This compound is currently undergoing a pivotal Phase III clinical trial for eosinophilic gastritis and/or duodenitis. It is also being evaluated in a Phase II/III study for eosinophilic esophagitis, and a Phase II trial for atopic dermatitis and chronic spontaneous urticaria. Furthermore, Allakos is exploring lirentelimab (AK002) for potential use in mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. In parallel, their pipeline includes AK006, another candidate being developed to tackle various allergic and inflammatory diseases. Established in 2012, Allakos Inc. operates from its headquarters located in Redwood City, California.

Key metrics

Market cap

$29.74M

P/E (TTM)

-0.42

EPS (TTM)

$-0.78

Beta

0.14

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$0.27

200-day avg

$0.74

52-week high

$1.56

52-week low

$0.22

CEO

Robert Alexander

ETFs linked to ALLK

Broad-market and Healthcare sector ETFs an investor holding Allakos is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ALLK fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ALLK in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Allakos?: Allakos trades under the ticker ALLK on NASDAQ.
Which exchange is ALLK listed on?: ALLK is listed on NASDAQ.
What sector does Allakos operate in?: Allakos is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ALLK in a portfolio?: PortView shows ALLK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.